Related Experiment Video
Updated: Jun 5, 2026
07:05
Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
Published on: May 17, 2015
Cardiac transplant graft arteriosclerosis.
1Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Trends in Cardiovascular Medicine
|January 18, 2011
Summary
Transplant-associated coronary arteriosclerosis is a major cause of late death after heart transplantation. Immunologic mechanisms, involving T-lymphocytes and macrophages, likely drive smooth muscle cell proliferation in these obstructive lesions.
Area of Science:
- Cardiology
- Immunology
- Transplantation
Background:
- Transplant-associated coronary arteriosclerosis (TACA) is a leading cause of late mortality following heart transplantation.
- TACA presents as an obstructive, proliferative lesion in the coronary arteries of transplanted hearts, often developing within months.
- Diagnosis and treatment of TACA are challenging due to graft denervation and the diffuse nature of the lesions.
Purpose of the Study:
- To elucidate the underlying mechanisms and characteristics of transplant-associated coronary arteriosclerosis.
- To differentiate TACA from typical coronary atherosclerosis.
- To identify potential immunologic contributors to TACA development.
Main Methods:
- Morphological analysis of graft arteriosclerotic lesions.
- Examination of cellular components within the lesions, including T-lymphocytes and macrophages.
- Investigation of the role of smooth muscle cells and extracellular matrix in lesion formation.
- Exploration of potential immunologic pathways, such as cytokine-driven proliferation.
Main Results:
- TACA lesions are morphologically distinct from typical coronary atherosclerosis.
- Lesions feature T-lymphocytes and macrophages beneath an intact endothelium.
- Obstructive lesions are primarily composed of smooth muscle cells and extracellular matrix.
- Immunologic mechanisms, potentially involving chronic cell-mediated immune responses, are implicated in TACA pathogenesis.
Conclusions:
- Transplant-associated coronary arteriosclerosis is driven by immunologic mechanisms.
- Cytokine-driven smooth muscle cell proliferation, stimulated by immune responses, likely contributes to lesion development.
- Understanding these mechanisms is crucial for improving diagnosis and treatment of TACA.
